BioCentury
ARTICLE | Company News

Idun, Becton, Dickinson and Co. deal

January 24, 2000 8:00 AM UTC

Becton, Dickinson’s BD Biosciences business received an exclusive license, including sublicensing rights, to sell Idun’s apoptosis reagents to the research market. Idun will receive an upfront payment...